Literature DB >> 3015764

Inclusion body myositis: a chronic persistent mumps myositis?

S M Chou.   

Abstract

Among the generalized chronic idiopathic inflammatory myopathies, inclusion body myositis (IBM) has emerged as a clinico-pathologic variant during the past two decades. It occurs primarily in elderly persons (in approximately the sixth decade of life), but young adults (in approximately the second decade of life) may also be affected. Slowly progressive weakness of distal as well as proximal muscle groups in IBM is usually not associated with skin rash, malignancy or collagen-vascular disease, and is refractory to treatment with steroids or other immunosuppressants. Exceptions to each of these general rules have been found. Muscle biopsy and electromyography may suggest a neurogenic process mixed with myopathic features. Rimmed vacuoles with basophilic granules in cryostat sections stained with hematoxylin-eosin are strongly suggestive of IBM if accompanied by the histopathologic triad of polymyositis. The presence of eosinophilic intranuclear or cytoplasmic inclusions in affected myofibers is further suggestive of IBM. The ultimate diagnosis, however, depends on ultrastructural demonstration of characteristic microtubular filaments resembling the nucleocapsids of the paramyxovirus group. Recent reports of immunostaining of the inclusions for mumps virus antigen strongly suggest a chronic persistent mumps virus infection as the cause of IBM. IBM is considered to be pathologically related to both distal myopathy (DM) and oculopharyngeal muscular dystrophy (OPMD).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015764     DOI: 10.1016/s0046-8177(86)80197-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

Review 1.  The idiopathic inflammatory myopathies and their treatment.

Authors:  J Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

2.  Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander).

Authors:  K Borg; F M Tomé; L Edström
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 3.  Sporadic viral myositis in two adults.

Authors:  C D Naylor; A M Jevnikar; N J Witt
Journal:  CMAJ       Date:  1987-11-01       Impact factor: 8.262

Review 4.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

5.  Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

Authors:  D Figarella-Branger; J F Pellissier; N Bianco; B Devictor; M Toga
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Adult-onset rod disease with abundant intranuclear rods.

Authors:  W Paulus; J Peiffer; I Becker; W Roggendorf; F Schumm
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

Review 7.  Inflammatory myositis in association with inflammatory bowel disease.

Authors:  A Kulkarni; T J Ravi; G J Brodmerkel; R M Agrawal
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.487

8.  Inclusion body myositis with abundant ring fibers.

Authors:  M R Del Bigio; V Jay
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors:  S Beyenburg; S Zierz; F Jerusalem
Journal:  Clin Investig       Date:  1993-05

10.  Dysphagia in inclusion body myositis.

Authors:  A R Wintzen; G T Bots; H M de Bakker; J H Hulshof; G W Padberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.